To reduce barriers to clozapine use, prescribers should collaborate with primary care physicians to ...

When prescribing clozapine—the only antipsychotic that has been FDA-approved for treatment-resistant...

Patients with schizophrenia who take antipsychotics commonly experience serious adverse metabolic ef...

The proportion of new clozapine trials for Medicaid patients with schizophrenia, among all new outpa...

Clozapine continues to be dramatically underutilized—despite it being the only drug approved for tre...

Last month, the FDA announced that beginning on October 12, all prescribers of clozapine—a medicatio...

Yesterday, the Food and Drug Administration announced that it is making changes to the requirements ...

Treatment with clozapine alone instead of antipsychotic polypharmacy for treatment-resistant schizop...

Electroconvulsive therapy (ECT) may have a role as a therapy augmentation when patients with schizop...